BENDAMUSTINE HYDROCHLORIDE

BENDAMUSTINE HYDROCHLORIDE was reported 8517 times

BENDAMUSTINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ELECTRODESICCATION 4 0.6667
1 B-CELL SMALL LYMPHOCYTIC LYMPHOMA RECURRENT 6 0.2727
2 ASCENDING FLACCID PARALYSIS 5 0.1852
3 CHONDROSARCOMA METASTATIC 4 0.1481
4 MANTLE CELL LYMPHOMA RECURRENT 58 0.1333
5 FOLLICULAR LYMPHOMA RECURRENT 10 0.1250
6 INFUSION SITE PHLEBITIS 27 0.1184
7 EXPOSURE VIA CONTAMINATED DEVICE 5 0.1136
8 FOLLICULAR LYMPHOMA REFRACTORY 7 0.1077
9 LYMPHOMA TRANSFORMATION 36 0.1000
10 ERYTHROPOIESIS ABNORMAL 25 0.0817
11 CORONAVIRUS PNEUMONIA 13 0.0778
12 APOPTOTIC COLONOPATHY 6 0.0723
13 PARANEOPLASTIC PEMPHIGUS 8 0.0615
14 CYTOMEGALOVIRUS ENTEROCOLITIS 46 0.0597
15 TUMOUR OBSTRUCTION 5 0.0575
16 FOLLICULAR LYMPHOMA 47 0.0534
17 METASTASES TO RETROPERITONEUM 9 0.0529
18 LEUKAEMIA CUTIS 8 0.0519
19 INJECTION SITE PHLEBITIS 12 0.0513
20 METASTASES TO MUSCLE 9 0.0497
21 CYTOMEGALOVIRUS CHORIORETINITIS 88 0.0451
22 BREAKTHROUGH COVID-19 10 0.0435
23 VASOGENIC CEREBRAL OEDEMA 28 0.0389
24 CD4 LYMPHOCYTES DECREASED 81 0.0378
25 ASPIRATION BONE MARROW ABNORMAL 5 0.0370
26 HUMORAL IMMUNE DEFECT 13 0.0350
27 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 77 0.0349
28 MANTLE CELL LYMPHOMA 51 0.0335
29 CYTOMEGALOVIRUS TEST POSITIVE 57 0.0320
30 THERAPY RESPONDER 15 0.0305
31 POLYCHROMASIA 9 0.0300
32 INFUSION SITE IRRITATION 38 0.0296
33 ATYPICAL MYCOBACTERIAL PNEUMONIA 4 0.0288
34 CELL-MEDIATED IMMUNE DEFICIENCY 4 0.0286
35 CYTOMEGALOVIRUS GASTROENTERITIS 6 0.0278
36 ALOPECIA SCARRING 5 0.0273
37 NASAL ABSCESS 6 0.0260
38 B-CELL LYMPHOMA RECURRENT 14 0.0258
39 CYTOMEGALOVIRUS HEPATITIS 9 0.0254
40 CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT 17 0.0244
41 BONE MARROW INFILTRATION 9 0.0233
42 ENCEPHALITIS CYTOMEGALOVIRUS 10 0.0228
43 CHRONIC LYMPHOCYTIC LEUKAEMIA 108 0.0227
44 LISTERIA SEPSIS 6 0.0227
45 EXTRAVASATION 93 0.0226
46 POST-ACUTE COVID-19 SYNDROME 28 0.0226
47 DIFFUSE LARGE B-CELL LYMPHOMA 174 0.0226
48 METASTASES TO BONE MARROW 11 0.0220
49 METASTASES TO SPLEEN 9 0.0218
50 HYPERTENSIVE CARDIOMYOPATHY 6 0.0216
51 CEREBRAL ASPERGILLOSIS 13 0.0211
52 GRANULOMA SKIN 17 0.0207
53 SKIN NEOPLASM EXCISION 16 0.0204
54 HYPOGAMMAGLOBULINAEMIA 127 0.0193
55 PNEUMONIA CYTOMEGALOVIRAL 36 0.0185
56 IMMUNODEFICIENCY COMMON VARIABLE 9 0.0184
57 ECTHYMA 7 0.0175
58 URETHRAL OBSTRUCTION 7 0.0173
59 APLASIA PURE RED CELL 58 0.0168
60 TUMOUR LYSIS SYNDROME 148 0.0168
61 PLASMA CELL LEUKAEMIA 10 0.0167
62 CLOSTRIDIAL SEPSIS 4 0.0165
63 CYTOMEGALOVIRUS INFECTION REACTIVATION 73 0.0165
64 NEUROENDOCRINE CARCINOMA OF THE SKIN 16 0.0163
65 CYTOMEGALOVIRUS INFECTION 271 0.0163
66 INFUSION SITE REACTION 48 0.0161
67 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 132 0.0160
68 GASTROINTESTINAL FUNGAL INFECTION 8 0.0155
69 BETA 2 MICROGLOBULIN INCREASED 4 0.0153
70 COAGULATION FACTOR V LEVEL DECREASED 5 0.0153
71 HUMAN POLYOMAVIRUS INFECTION 8 0.0151
72 CYTOMEGALOVIRUS VIRAEMIA 67 0.0150
73 VEIN DISCOLOURATION 7 0.0149
74 LYMPHOCYTE COUNT DECREASED 263 0.0149
75 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 14 0.0148
76 PNEUMONIA ESCHERICHIA 5 0.0147
77 WOUND NECROSIS 7 0.0146
78 CYTOPENIA 174 0.0142
79 PRESCRIBED UNDERDOSE 276 0.0138
80 ERYTHEMA ANNULARE 4 0.0138
81 OBLITERATIVE BRONCHIOLITIS 18 0.0137
82 CYSTITIS VIRAL 5 0.0131
83 CONGENITAL APLASIA 4 0.0129
84 COVID-19 PNEUMONIA 146 0.0124
85 ENTEROCOCCAL SEPSIS 10 0.0123
86 KLEBSIELLA TEST POSITIVE 8 0.0123
87 SINUS POLYP 7 0.0121
88 ANAEMIA HAEMOLYTIC AUTOIMMUNE 10 0.0121
89 ORAL LICHEN PLANUS 6 0.0120
90 PROCALCITONIN INCREASED 14 0.0119
91 OPPORTUNISTIC INFECTION 22 0.0119
92 TUMOUR FLARE 8 0.0117
93 BLOOD LACTATE DEHYDROGENASE INCREASED 182 0.0115
94 BLOOD PARATHYROID HORMONE DECREASED 17 0.0115
95 FUNGAL TEST POSITIVE 4 0.0114
96 INFUSION SITE EXTRAVASATION 71 0.0114
97 AUTOIMMUNE HAEMOLYTIC ANAEMIA 39 0.0114
98 FUNGAL OESOPHAGITIS 8 0.0113
99 VIRAL HAEMORRHAGIC CYSTITIS 8 0.0112
100 HEPATITIS VIRAL 9 0.0112
101 PNEUMONIA PSEUDOMONAL 17 0.0111
102 CORONAVIRUS INFECTION 71 0.0107
103 ANISOCYTOSIS 7 0.0107
104 PLASMA CELL MYELOMA REFRACTORY 14 0.0105
105 NEUTROPHIL COUNT DECREASED 424 0.0104
106 ABDOMINAL LYMPHADENOPATHY 9 0.0104
107 CANDIDA SEPSIS 9 0.0100
108 B-CELL LYMPHOMA 34 0.0100
109 NON-HODGKIN'S LYMPHOMA 13 0.0099
110 SCROTAL OEDEMA 7 0.0098
111 HEPATITIS B REACTIVATION 31 0.0098
112 INFECTION IN AN IMMUNOCOMPROMISED HOST 7 0.0097
113 B-LYMPHOCYTE COUNT DECREASED 13 0.0095
114 CYTOMEGALOVIRUS COLITIS 21 0.0091
115 ORGANISING PNEUMONIA 45 0.0091
116 NEOPLASM SKIN 14 0.0090
117 PULMONARY MYCOSIS 7 0.0090
118 IMMUNE THROMBOCYTOPENIC PURPURA 25 0.0088
119 BIOPSY BONE MARROW ABNORMAL 4 0.0088
120 FEBRILE INFECTION 10 0.0085
121 PNEUMOCOCCAL INFECTION 5 0.0084
122 VACCINATION FAILURE 14 0.0084
123 ORAL FUNGAL INFECTION 23 0.0084
124 CRYOGLOBULINAEMIA 6 0.0084
125 PHLEBITIS 43 0.0084
126 MYELODYSPLASTIC SYNDROME 121 0.0084
127 MALIGNANT PLEURAL EFFUSION 14 0.0083
128 PANNICULITIS 20 0.0083
129 VARICELLA ZOSTER VIRUS INFECTION 17 0.0082
130 JC VIRUS INFECTION 13 0.0081
131 EVANS SYNDROME 4 0.0081
132 BLOOD IMMUNOGLOBULIN G DECREASED 20 0.0081
133 FEBRILE NEUTROPENIA 534 0.0080
134 EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE) 4 0.0079
135 MYELOSUPPRESSION 282 0.0078
136 DEMYELINATING POLYNEUROPATHY 8 0.0078
137 MUCOSAL EROSION 7 0.0077
138 HEPATITIS E 12 0.0076
139 CHRONIC MYELOMONOCYTIC LEUKAEMIA 5 0.0076
140 SECOND PRIMARY MALIGNANCY 63 0.0076
141 VULVAL DISORDER 5 0.0076
142 GRANULOCYTE COUNT DECREASED 14 0.0075
143 DYSPLASIA 9 0.0075
144 CEREBRAL TOXOPLASMOSIS 7 0.0075
145 HERPES ZOSTER DISSEMINATED 6 0.0075
146 INFUSION SITE INDURATION 11 0.0074
147 SECONDARY IMMUNODEFICIENCY 9 0.0074
148 NEUTROPENIC INFECTION 7 0.0073
149 PNEUMOCYSTIS JIROVECII PNEUMONIA 71 0.0071
150 PRINZMETAL ANGINA 7 0.0070
151 ORTHOSTATIC INTOLERANCE 5 0.0070
152 PANCYTOPENIA 386 0.0069
153 METASTASIS 49 0.0069
154 INFUSION SITE DISCOLOURATION 6 0.0068
155 ABDOMINAL SEPSIS 6 0.0068
156 CRYPTOCOCCOSIS 11 0.0067
157 BLISTER RUPTURE 5 0.0067
158 URINARY TRACT INFECTION BACTERIAL 17 0.0067
159 APLASIA 13 0.0066
160 DERMATITIS EXFOLIATIVE GENERALISED 23 0.0066
161 VASCULITIC RASH 5 0.0065
162 BLOOD BILIRUBIN DECREASED 4 0.0065
163 NEUTROPENIC SEPSIS 46 0.0064
164 VASCULAR PAIN 6 0.0063
165 LYMPHOPENIA 89 0.0063
166 PNEUMOCYSTIS JIROVECI PNEUMONIA 14 0.0063
167 BACTERAEMIA 74 0.0062
168 THERAPY PARTIAL RESPONDER 97 0.0062
169 HAEMATOTOXICITY 59 0.0062
170 RHEUMATOID NODULE 17 0.0062
171 INFUSION SITE PAIN 79 0.0061
172 ACUTE MYELOID LEUKAEMIA 95 0.0061
173 INFUSION SITE OEDEMA 5 0.0060
174 JC POLYOMAVIRUS TEST POSITIVE 7 0.0060
175 BRONCHOPULMONARY ASPERGILLOSIS 46 0.0059
176 HAEMOLYTIC ANAEMIA 53 0.0059
177 PSEUDOMEMBRANOUS COLITIS 13 0.0058
178 ENTEROVIRUS INFECTION 5 0.0058
179 NEUROLOGICAL SYMPTOM 33 0.0058
180 SERUM SICKNESS 16 0.0057
181 BONE MARROW FAILURE 115 0.0057
182 LYMPHOMA 87 0.0056
183 VENOOCCLUSIVE DISEASE 14 0.0056
184 CHYLOTHORAX 4 0.0055
185 ADENOCARCINOMA GASTRIC 5 0.0054
186 ENTEROCOCCAL INFECTION 26 0.0054
187 ASPERGILLOSIS 7 0.0054
188 FEAR OF INJECTION 38 0.0053
189 DEBRIDEMENT 4 0.0052
190 NEPHROGENIC DIABETES INSIPIDUS 6 0.0052
191 STAPHYLOCOCCAL BACTERAEMIA 22 0.0051
192 RASH MORBILLIFORM 14 0.0050
193 RASH MACULO-PAPULAR 111 0.0050
194 HEPATITIS B 30 0.0050
195 POST HERPETIC NEURALGIA 7 0.0049
196 VENOOCCLUSIVE LIVER DISEASE 24 0.0049
197 DISEASE PROGRESSION 572 0.0048
198 INFUSION SITE DISCOMFORT 5 0.0048
199 END STAGE RENAL DISEASE 88 0.0048
200 GIANT CELL ARTERITIS 4 0.0048
201 SQUAMOUS CELL CARCINOMA 45 0.0048
202 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 11 0.0047
203 NEOPLASM RECURRENCE 16 0.0047
204 FEBRILE BONE MARROW APLASIA 20 0.0047
205 HYPERCALCAEMIA 58 0.0047
206 BACTERIAL SEPSIS 15 0.0046
207 STREPTOCOCCAL BACTERAEMIA 5 0.0046
208 ACARODERMATITIS 5 0.0046
209 LISTERIOSIS 5 0.0045
210 HYPERLEUKOCYTOSIS 4 0.0045
211 EPSTEIN-BARR VIRAEMIA 5 0.0045
212 CYTOKINE RELEASE SYNDROME 90 0.0045
213 SQUAMOUS CELL CARCINOMA OF SKIN 27 0.0045
214 INFUSION SITE SWELLING 28 0.0044
215 KLEBSIELLA SEPSIS 5 0.0044
216 SYSTEMIC CANDIDA 11 0.0044
217 LOBAR PNEUMONIA 8 0.0043
218 PNEUMONIA FUNGAL 17 0.0043
219 H1N1 INFLUENZA 6 0.0043
220 HYDRONEPHROSIS 32 0.0043
221 SKIN NECROSIS 22 0.0042
222 MYOSITIS 38 0.0042
223 PNEUMONIA INFLUENZAL 5 0.0042
224 UPPER RESPIRATORY TRACT INFLAMMATION 5 0.0042
225 GASTROINTESTINAL TOXICITY 20 0.0042
226 PLATELET COUNT DECREASED 442 0.0041
227 ADENOVIRUS INFECTION 12 0.0041
228 RED BLOOD CELL COUNT ABNORMAL 6 0.0041
229 BREATH SOUNDS ABNORMAL 20 0.0041
230 PARESIS 9 0.0040
231 ADENOCARCINOMA 9 0.0040
232 ADMINISTRATION SITE EXTRAVASATION 4 0.0040
233 KLEBSIELLA INFECTION 20 0.0040
234 INFUSION RELATED REACTION 262 0.0039
235 PERIPHERAL SENSORY NEUROPATHY 23 0.0039
236 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 15 0.0039
237 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 23 0.0039
238 RED CELL DISTRIBUTION WIDTH INCREASED 16 0.0038
239 BASAL CELL CARCINOMA 60 0.0038
240 ERYSIPELAS 19 0.0038
241 PLASMACYTOMA 7 0.0038
242 ADENOCARCINOMA OF COLON 7 0.0037
243 IMMUNE THROMBOCYTOPENIA 17 0.0037
244 MALIGNANT NEOPLASM PROGRESSION 380 0.0037
245 NEUTROPENIA 501 0.0037
246 LYMPHADENOPATHY 130 0.0037
247 ASPERGILLUS INFECTION 24 0.0037
248 HYPERURICAEMIA 15 0.0036
249 ENTEROCOLITIS 21 0.0036
250 PSEUDOMONAS INFECTION 31 0.0036
251 STEVENS-JOHNSON SYNDROME 80 0.0036
252 PERIPHERAL MOTOR NEUROPATHY 5 0.0036
253 CLOSTRIDIAL INFECTION 12 0.0035
254 ESCHERICHIA URINARY TRACT INFECTION 15 0.0035
255 DIFFUSE ALVEOLAR DAMAGE 4 0.0035
256 ACUTE SINUSITIS 6 0.0035
257 CYSTITIS HAEMORRHAGIC 14 0.0035
258 ILEUS 43 0.0035
259 APLASTIC ANAEMIA 18 0.0034
260 SPINAL CORD INJURY 6 0.0034
261 MULTIPLE MYELOMA 16 0.0034
262 MENINGITIS CRYPTOCOCCAL 6 0.0034
263 HYPERTHERMIA 26 0.0034
264 PNEUMONIA PNEUMOCOCCAL 5 0.0034
265 EOSINOPHILIA 59 0.0034
266 HAEMOLYSIS 26 0.0034
267 DRUG TOLERANCE 17 0.0034
268 SPLENOMEGALY 39 0.0033
269 SUSPECTED OFF LABEL USE 15 0.0033
270 GUILLAIN-BARRE SYNDROME 16 0.0033
271 THROMBOCYTOPENIA 367 0.0033
272 PNEUMONIA BACTERIAL 30 0.0033
273 LYMPHOCYTOSIS 7 0.0032
274 WHITE BLOOD CELL COUNT DECREASED 352 0.0032
275 STAPHYLOCOCCAL SEPSIS 16 0.0032
276 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 4 0.0032
277 INFUSION SITE ERYTHEMA 27 0.0032
278 DISSEMINATED INTRAVASCULAR COAGULATION 45 0.0032
279 NEUTROPHIL COUNT ABNORMAL 9 0.0032
280 OSTEOSCLEROSIS 5 0.0032
281 IDIOPATHIC THROMBOCYTOPENIC PURPURA 5 0.0032
282 DRUG ERUPTION 56 0.0032
283 BLOOD URIC ACID INCREASED 18 0.0031
284 VASCULITIS 36 0.0031
285 RHINOVIRUS INFECTION 12 0.0031
286 PLASMA CELL MYELOMA RECURRENT 10 0.0031
287 TOXIC SKIN ERUPTION 31 0.0031
288 LYMPHOCYTE COUNT INCREASED 10 0.0031
289 SEPTIC SHOCK 133 0.0031
290 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 4 0.0030
291 AGRANULOCYTOSIS 56 0.0030
292 GASTROENTERITIS NOROVIRUS 4 0.0030
293 DERMATITIS EXFOLIATIVE 15 0.0030
294 DEVICE RELATED SEPSIS 6 0.0030
295 ESCHERICHIA BACTERAEMIA 7 0.0030
296 BLOOD COUNT ABNORMAL 45 0.0030
297 RHEUMATOID FACTOR POSITIVE 17 0.0029
298 TYPE IV HYPERSENSITIVITY REACTION 8 0.0029
299 CENTRAL NERVOUS SYSTEM LYMPHOMA 4 0.0029
300 RETINITIS 5 0.0029
301 PSEUDOMONAL SEPSIS 5 0.0029
302 THROMBOPHLEBITIS 10 0.0028
303 SKIN TOXICITY 16 0.0028
304 ATYPICAL MYCOBACTERIAL INFECTION 4 0.0028
305 PNEUMONIA VIRAL 9 0.0028
306 VEIN DISORDER 14 0.0028
307 BRAIN ABSCESS 7 0.0028
308 OESOPHAGEAL CANDIDIASIS 11 0.0028
309 NOCARDIOSIS 7 0.0027
310 OTITIS MEDIA 9 0.0027
311 IMMUNOSUPPRESSION 24 0.0027
312 BACTERIAL TEST POSITIVE 6 0.0027
313 LUNG OPACITY 7 0.0027
314 C-REACTIVE PROTEIN ABNORMAL 17 0.0026
315 PLASMA CELL MYELOMA 102 0.0026
316 UROSEPSIS 24 0.0026
317 LICHEN PLANUS 6 0.0026
318 BLOOD PHOSPHORUS INCREASED 7 0.0026
319 CANDIDA INFECTION 43 0.0025
320 FEMORAL NECK FRACTURE 13 0.0025
321 MUCOSAL INFLAMMATION 66 0.0025
322 NON-SMALL CELL LUNG CANCER 12 0.0025
323 LUNG CONSOLIDATION 7 0.0025
324 PYREXIA 865 0.0025
325 ATELECTASIS 24 0.0025
326 RESPIRATORY SYMPTOM 7 0.0025
327 DIVERTICULAR PERFORATION 5 0.0024
328 NEOPLASM PROGRESSION 84 0.0024
329 ESCHERICHIA SEPSIS 7 0.0024
330 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 18 0.0024
331 COVID-19 412 0.0023
332 ANAEMIA MACROCYTIC 5 0.0023
333 ORAL DISORDER 17 0.0023
334 NEPHROPATHY TOXIC 26 0.0023
335 SEPSIS 258 0.0023
336 GLOMERULAR FILTRATION RATE DECREASED 28 0.0023
337 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 4 0.0023
338 CLOSTRIDIUM DIFFICILE COLITIS 24 0.0023
339 HEPATIC FUNCTION ABNORMAL 83 0.0022
340 INFLAMMATORY MARKER INCREASED 11 0.0022
341 SKIN REACTION 31 0.0022
342 METASTASES TO MENINGES 5 0.0022
343 HYPOALBUMINAEMIA 17 0.0022
344 VENTRICULAR HYPOKINESIA 7 0.0022
345 HERPES ZOSTER 125 0.0022
346 SKIN EROSION 7 0.0022
347 GASTROINTESTINAL PERFORATION 9 0.0022
348 LUNG INFILTRATION 19 0.0021
349 PEMPHIGOID 16 0.0021
350 FAILURE TO THRIVE 11 0.0021
351 AORTIC VALVE INCOMPETENCE 9 0.0021
352 PULMONARY TUBERCULOSIS 9 0.0021
353 PLEURAL EFFUSION 127 0.0021
354 ANAEMIA 395 0.0021
355 ACUTE CORONARY SYNDROME 17 0.0021
356 ORAL CANDIDIASIS 27 0.0020
357 HYPOGEUSIA 4 0.0020
358 C-REACTIVE PROTEIN INCREASED 74 0.0020
359 NEUROPATHY PERIPHERAL 193 0.0020
360 HYPERBILIRUBINAEMIA 21 0.0020
361 ENCEPHALITIS 14 0.0020
362 HISTIOCYTOSIS HAEMATOPHAGIC 6 0.0020
363 AORTIC STENOSIS 7 0.0020
364 ATYPICAL PNEUMONIA 6 0.0020
365 HERPES SIMPLEX 13 0.0020
366 LEUKOPENIA 100 0.0020
367 HYPOAESTHESIA ORAL 30 0.0020
368 JAUNDICE CHOLESTATIC 7 0.0020
369 INGUINAL HERNIA 12 0.0020
370 RECURRENT CANCER 8 0.0020
371 MENINGITIS 13 0.0019
372 CACHEXIA 10 0.0019
373 INTERSTITIAL LUNG DISEASE 94 0.0019
374 GENERALISED OEDEMA 24 0.0019
375 CAPILLARY LEAK SYNDROME 4 0.0019
376 PERFORMANCE STATUS DECREASED 9 0.0019
377 MUCORMYCOSIS 5 0.0019
378 PSYCHOMOTOR SKILLS IMPAIRED 5 0.0019
379 DRUG RESISTANCE 49 0.0019
380 IMMUNE SYSTEM DISORDER 25 0.0019
381 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 5 0.0019
382 ATRIAL FLUTTER 15 0.0019
383 LEUKOENCEPHALOPATHY 7 0.0019
384 HYPERTRANSAMINASAEMIA 13 0.0019
385 HYPERLACTACIDAEMIA 5 0.0019
386 FAECALOMA 10 0.0018
387 DEVICE RELATED INFECTION 28 0.0018
388 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 6 0.0018
389 CYTOLYTIC HEPATITIS 6 0.0018
390 EMBOLISM 15 0.0018
391 LUNG INFECTION 28 0.0018
392 CARDIAC FAILURE ACUTE 12 0.0018
393 LEFT VENTRICULAR DYSFUNCTION 12 0.0018
394 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 9 0.0018
395 DERMATITIS 37 0.0018
396 MULTIPLE ORGAN DYSFUNCTION SYNDROME 50 0.0018
397 GENERALISED ERYTHEMA 10 0.0018
398 POLYNEUROPATHY 21 0.0018
399 BRONCHOPNEUMONIA 6 0.0018
400 BLOOD DISORDER 14 0.0017
401 THROMBOTIC MICROANGIOPATHY 17 0.0017
402 CHILLS 204 0.0017
403 PULMONARY FIBROSIS 33 0.0017
404 HYPOVOLAEMIA 10 0.0017
405 AORTIC DISSECTION 7 0.0017
406 PNEUMONITIS 46 0.0017
407 HEPATITIS FULMINANT 5 0.0017
408 ATRIAL FIBRILLATION 164 0.0017
409 PRODUCT USE IN UNAPPROVED INDICATION 416 0.0017
410 ASPARTATE AMINOTRANSFERASE INCREASED 89 0.0017
411 HYPOVOLAEMIC SHOCK 8 0.0017
412 BLOOD CULTURE POSITIVE 5 0.0017
413 BACTERIAL INFECTION 31 0.0017
414 BONE MARROW DISORDER 5 0.0017
415 THROMBOPHLEBITIS SUPERFICIAL 5 0.0016
416 NONSPECIFIC REACTION 9 0.0016
417 GLOMERULONEPHRITIS 4 0.0016
418 RED BLOOD CELL SEDIMENTATION RATE INCREASED 18 0.0016
419 AMYLASE INCREASED 6 0.0016
420 RASH GENERALISED 42 0.0016
421 BLOOD PRESSURE DECREASED 107 0.0016
422 ANGIOPATHY 9 0.0016
423 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 41 0.0016
424 ESCHERICHIA INFECTION 13 0.0016
425 TROPONIN INCREASED 12 0.0016
426 RED BLOOD CELL COUNT DECREASED 45 0.0016
427 NEOPLASM 18 0.0016
428 HAEMOGLOBIN ABNORMAL 10 0.0016
429 INFECTION 221 0.0015
430 DEAFNESS NEUROSENSORY 5 0.0015
431 BLOOD LACTIC ACID INCREASED 8 0.0015
432 ULCER 24 0.0015
433 ODYNOPHAGIA 9 0.0015
434 CREATININE RENAL CLEARANCE DECREASED 6 0.0015
435 ABDOMINAL MASS 4 0.0015
436 CARDIOMYOPATHY 22 0.0015
437 GASTROINTESTINAL INJURY 4 0.0015
438 ANAL ABSCESS 8 0.0015
439 BK VIRUS INFECTION 5 0.0015
440 ALANINE AMINOTRANSFERASE INCREASED 90 0.0015
441 HAEMATOCRIT DECREASED 29 0.0015
442 ARTHRITIS BACTERIAL 6 0.0015
443 TOXIC EPIDERMAL NECROLYSIS 22 0.0014
444 HYPOXIA 51 0.0014
445 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 4 0.0014
446 PNEUMONIA 468 0.0014
447 GRANULOMA 5 0.0014
448 RESPIRATORY FAILURE 104 0.0014
449 ACUTE PULMONARY OEDEMA 8 0.0014
450 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 78 0.0014
451 HYPERPYREXIA 6 0.0014
452 PULMONARY TOXICITY 10 0.0014
453 ENTERITIS 9 0.0014
454 GRANULOCYTOPENIA 8 0.0014
455 GAMMA-GLUTAMYLTRANSFERASE INCREASED 31 0.0014
456 ERYTHEMA MULTIFORME 13 0.0014
457 GRAFT VERSUS HOST DISEASE 10 0.0014
458 CHRONIC GRAFT VERSUS HOST DISEASE 5 0.0014
459 REFUSAL OF TREATMENT BY PATIENT 9 0.0014
460 METABOLIC DISORDER 8 0.0014
461 OESOPHAGITIS 15 0.0014
462 RASH PRURITIC 74 0.0014
463 BRONCHIECTASIS 9 0.0013
464 STOMATITIS 81 0.0013
465 SUBDURAL HAEMATOMA 19 0.0013
466 GENERAL PHYSICAL CONDITION ABNORMAL 9 0.0013
467 PLATELET COUNT ABNORMAL 8 0.0013
468 EMBOLISM VENOUS 4 0.0013
469 DUODENITIS 4 0.0013
470 HYPOKALAEMIA 60 0.0013
471 OFF LABEL USE 1135 0.0013
472 HEPATITIS 33 0.0013
473 OLIGURIA 8 0.0013
474 BLOOD TEST ABNORMAL 18 0.0013
475 EPSTEIN-BARR VIRUS INFECTION 8 0.0013
476 RASH 558 0.0013
477 ANURIA 11 0.0013
478 IMMUNODEFICIENCY 19 0.0013
479 STAPHYLOCOCCAL INFECTION 42 0.0013
480 VENTRICULAR TACHYCARDIA 21 0.0013
481 THERAPY NON-RESPONDER 57 0.0013
482 LIVER DISORDER 56 0.0013
483 ASCITES 37 0.0013
484 STREPTOCOCCAL INFECTION 7 0.0013
485 SUPRAVENTRICULAR TACHYCARDIA 12 0.0013
486 MALNUTRITION 14 0.0013
487 TACHYPNOEA 17 0.0012
488 ACUTE RESPIRATORY DISTRESS SYNDROME 22 0.0012
489 ORGAN FAILURE 5 0.0012
490 NODULE 16 0.0012
491 RENAL TUBULAR NECROSIS 12 0.0012
492 HERPES VIRUS INFECTION 7 0.0012
493 PATHOGEN RESISTANCE 11 0.0012
494 ACUTE KIDNEY INJURY 184 0.0012
495 HYPOTONIA 12 0.0012
496 EOSINOPHIL COUNT INCREASED 10 0.0012
497 NEUROTOXICITY 21 0.0012
498 COLITIS 45 0.0012
499 COLITIS ISCHAEMIC 8 0.0012
500 HEPATIC ENCEPHALOPATHY 11 0.0012
501 GOUT 21 0.0012
502 APHTHOUS ULCER 9 0.0012
503 INTESTINAL PERFORATION 13 0.0012
504 RESPIRATORY TRACT INFECTION 30 0.0012
505 HYPOMAGNESAEMIA 16 0.0011
506 ACUTE RESPIRATORY FAILURE 22 0.0011
507 VIRAL INFECTION 38 0.0011
508 POLYARTHRITIS 6 0.0011
509 RESPIRATORY DISTRESS 31 0.0011
510 DECREASED IMMUNE RESPONSIVENESS 11 0.0011
511 RASH PAPULAR 25 0.0011
512 MENINGITIS ASEPTIC 5 0.0011
513 HAEMOGLOBIN DECREASED 114 0.0011
514 BONE LESION 4 0.0011
515 VASCULAR DEVICE INFECTION 5 0.0011
516 HEPATIC CYTOLYSIS 14 0.0011
517 CUTANEOUS VASCULITIS 4 0.0011
518 ACUTE GRAFT VERSUS HOST DISEASE 5 0.0011
519 RASH ERYTHEMATOUS 52 0.0011
520 BLOOD CREATININE INCREASED 70 0.0011
521 CHRONIC SINUSITIS 4 0.0011
522 SARS-COV-2 TEST POSITIVE 14 0.0011
523 CARDIAC TAMPONADE 5 0.0011
524 HYPOTENSION 211 0.0011
525 LEUKOCYTOSIS 19 0.0010
526 RENAL IMPAIRMENT 88 0.0010
527 MYOCARDITIS 12 0.0010
528 SUBCUTANEOUS ABSCESS 5 0.0010
529 CHOLESTASIS 20 0.0010
530 SUDDEN DEATH 11 0.0010
531 METASTASES TO LYMPH NODES 7 0.0010
532 BLOOD BILIRUBIN INCREASED 28 0.0010
533 EJECTION FRACTION DECREASED 16 0.0010
534 BODY TEMPERATURE INCREASED 21 0.0010
535 CARDIOTOXICITY 9 0.0010
536 FACE OEDEMA 17 0.0010
537 GENERAL PHYSICAL HEALTH DETERIORATION 116 0.0010
538 AZOTAEMIA 4 0.0010
539 PNEUMONIA ASPIRATION 25 0.0010
540 CANDIDIASIS 4 0.0010
541 PRODUCT USE ISSUE 187 0.0010
542 PERICARDIAL EFFUSION 23 0.0010
543 FUNGAL INFECTION 33 0.0010
544 DISORIENTATION 39 0.0010
545 DEMYELINATION 4 0.0010
546 TUBULOINTERSTITIAL NEPHRITIS 18 0.0010
547 METASTASES TO LUNG 11 0.0010
548 HYPOCALCAEMIA 18 0.0010
549 SKIN LESION 26 0.0009
550 INTENTIONAL PRODUCT USE ISSUE 83 0.0009
551 SYNOVITIS 17 0.0009
552 RENAL FAILURE ACUTE 40 0.0009
553 ANAPHYLACTIC REACTION 52 0.0009
554 WHITE BLOOD CELL COUNT ABNORMAL 6 0.0009
555 INCORRECT DRUG ADMINISTRATION RATE 4 0.0009
556 CARDIAC FAILURE CHRONIC 4 0.0009
557 METASTASES TO CENTRAL NERVOUS SYSTEM 12 0.0009
558 MYOPATHY 8 0.0009
559 MULTI-ORGAN FAILURE 16 0.0009
560 DEHYDRATION 123 0.0009
561 SINUS TACHYCARDIA 13 0.0009
562 WHITE BLOOD CELL COUNT INCREASED 35 0.0009
563 ANKYLOSING SPONDYLITIS 12 0.0009
564 ADRENAL INSUFFICIENCY 11 0.0009
565 PURPURA 8 0.0009
566 NECROSIS 5 0.0009
567 LIVER FUNCTION TEST ABNORMAL 26 0.0009
568 SMALL INTESTINAL OBSTRUCTION 11 0.0009
569 REBOUND EFFECT 10 0.0009
570 PNEUMOTHORAX 14 0.0009
571 PERONEAL NERVE PALSY 5 0.0009
572 PULMONARY MASS 13 0.0009
573 CLOSTRIDIUM DIFFICILE INFECTION 19 0.0009
574 SKIN DISORDER 29 0.0009
575 PETECHIAE 9 0.0009
576 ELECTROLYTE IMBALANCE 10 0.0009
577 JAUNDICE 23 0.0009
578 METASTASES TO LIVER 15 0.0009
579 ANAPHYLACTIC SHOCK 22 0.0009
580 PULMONARY EMBOLISM 81 0.0009
581 HEPATIC CIRRHOSIS 16 0.0009
582 SPINAL COMPRESSION FRACTURE 7 0.0008
583 BLOOD ALKALINE PHOSPHATASE INCREASED 21 0.0008
584 DISEASE RECURRENCE 40 0.0008
585 HYPERSENSITIVITY 156 0.0008
586 CHOLECYSTITIS 10 0.0008
587 DELIRIUM 29 0.0008
588 HEPATIC FAILURE 25 0.0008
589 CARDIAC FAILURE 66 0.0008
590 ENCEPHALOPATHY 20 0.0008
591 DECREASED APPETITE 189 0.0008
592 INJECTION SITE EXTRAVASATION 10 0.0008
593 CONJUNCTIVITIS 15 0.0008
594 HEPATOTOXICITY 18 0.0008
595 PYELONEPHRITIS 7 0.0008
596 ACUTE HEPATIC FAILURE 11 0.0008
597 ORTHOSTATIC HYPOTENSION 14 0.0008
598 RESPIRATORY SYNCYTIAL VIRUS INFECTION 7 0.0008
599 HYPERNATRAEMIA 4 0.0008
600 SKIN INFECTION 9 0.0008
601 FLUID INTAKE REDUCED 4 0.0008
602 CELLULITIS 40 0.0008
603 THERAPEUTIC RESPONSE DECREASED 48 0.0008
604 HYPOPHAGIA 20 0.0008
605 NEUTROPHIL COUNT INCREASED 8 0.0008
606 CARDIAC DISORDER 73 0.0008
607 ACUTE MYOCARDIAL INFARCTION 23 0.0008
608 ENDOCARDITIS 4 0.0008
609 CEREBRAL ISCHAEMIA 4 0.0008
610 VENTRICULAR EXTRASYSTOLES 8 0.0008
611 TENDERNESS 8 0.0008
612 TACHYCARDIA 68 0.0008
613 CIRCULATORY COLLAPSE 13 0.0008
614 TREATMENT FAILURE 63 0.0008
615 OEDEMA 41 0.0008
616 GASTROENTERITIS 11 0.0008
617 RENAL FAILURE 100 0.0008
618 ERYTHEMA 154 0.0007
619 MALIGNANT MELANOMA 10 0.0007
620 FULL BLOOD COUNT DECREASED 15 0.0007
621 HYPERKALAEMIA 26 0.0007
622 SKIN ULCER 19 0.0007
623 HICCUPS 6 0.0007
624 ISCHAEMIC STROKE 13 0.0007
625 DRUG LEVEL BELOW THERAPEUTIC 4 0.0007
626 BRONCHITIS 53 0.0007
627 HAEMODIALYSIS 6 0.0007
628 LUNG DISORDER 35 0.0007
629 BLINDNESS 29 0.0007
630 PSYCHOTIC DISORDER 21 0.0007
631 INFLAMMATION 36 0.0007
632 SHOCK 16 0.0007
633 ALTERED STATE OF CONSCIOUSNESS 15 0.0007
634 PULMONARY OEDEMA 31 0.0007
635 SKIN SWELLING 6 0.0007
636 CYSTITIS 22 0.0007
637 HYPERVENTILATION 4 0.0007
638 DRUG EFFECT INCOMPLETE 25 0.0007
639 RASH PUSTULAR 5 0.0007
640 RASH MACULAR 24 0.0007
641 HYPOPHOSPHATAEMIA 5 0.0007
642 ATAXIA 8 0.0007
643 COLON CANCER 10 0.0007
644 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 35 0.0007
645 HEPATITIS CHOLESTATIC 4 0.0007
646 BLOOD UREA INCREASED 11 0.0007
647 NO THERAPEUTIC RESPONSE 8 0.0007
648 LIPASE INCREASED 5 0.0007
649 HEMIPARESIS 11 0.0006
650 FLANK PAIN 6 0.0006
651 INTESTINAL OBSTRUCTION 24 0.0006
652 DERMATITIS ALLERGIC 8 0.0006
653 LEUKAEMIA 6 0.0006
654 VENTRICULAR FIBRILLATION 7 0.0006
655 TRANSAMINASES INCREASED 14 0.0006
656 URINARY RETENTION 21 0.0006
657 TRICUSPID VALVE INCOMPETENCE 5 0.0006
658 PULMONARY HYPERTENSION 13 0.0006
659 SINUS BRADYCARDIA 6 0.0006
660 PRESCRIBED OVERDOSE 12 0.0006
661 SYNCOPE 62 0.0006
662 MITRAL VALVE INCOMPETENCE 7 0.0006
663 CEREBRAL INFARCTION 15 0.0006
664 DIVERTICULITIS 17 0.0006
665 HAEMATURIA 21 0.0006
666 LIVER INJURY 15 0.0006
667 FLUSHING 62 0.0006
668 CHOLELITHIASIS 20 0.0006
669 NERVOUS SYSTEM DISORDER 19 0.0006
670 DEEP VEIN THROMBOSIS 39 0.0006
671 EMPHYSEMA 6 0.0006
672 UPPER GASTROINTESTINAL HAEMORRHAGE 10 0.0006
673 MELAENA 13 0.0006
674 DRUG LEVEL DECREASED 6 0.0006
675 SUBARACHNOID HAEMORRHAGE 6 0.0006
676 CARDIAC ARREST 48 0.0006
677 MENTAL STATUS CHANGES 16 0.0006
678 ASTHENIA 216 0.0006
679 URINE OUTPUT DECREASED 5 0.0006
680 ARRHYTHMIA 27 0.0006
681 BLINDNESS UNILATERAL 8 0.0006
682 ABSCESS 9 0.0006
683 BLOOD PRESSURE SYSTOLIC INCREASED 11 0.0006
684 ORAL HERPES 11 0.0006
685 PEMPHIGUS 7 0.0006
686 GASTROINTESTINAL INFECTION 5 0.0006
687 DECREASED ACTIVITY 6 0.0006
688 DERMATITIS BULLOUS 4 0.0006
689 HYPERGLYCAEMIA 20 0.0005
690 DRUG INTOLERANCE 52 0.0005
691 APPENDICITIS 5 0.0005
692 HAEMORRHAGE INTRACRANIAL 8 0.0005
693 ABDOMINAL PAIN 124 0.0005
694 CEREBRAL HAEMORRHAGE 19 0.0005
695 PANCREATITIS 28 0.0005
696 CONSTIPATION 115 0.0005
697 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 5 0.0005
698 DIARRHOEA 336 0.0005
699 ATRIOVENTRICULAR BLOCK 4 0.0005
700 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 4 0.0005
701 HEPATIC ENZYME INCREASED 35 0.0005
702 VITREOUS FLOATERS 5 0.0005
703 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 36 0.0005
704 DYSARTHRIA 19 0.0005
705 FEELING COLD 14 0.0005
706 HEPATOCELLULAR INJURY 7 0.0005
707 DEATH 425 0.0005
708 TASTE DISORDER 10 0.0005
709 EYELID PTOSIS 5 0.0005
710 TOOTH ABSCESS 5 0.0005
711 MOTOR DYSFUNCTION 5 0.0005
712 PANCREATITIS ACUTE 11 0.0005
713 CARDIOGENIC SHOCK 7 0.0005
714 CARDIOMEGALY 6 0.0005
715 PRODUCT PREPARATION ERROR 10 0.0005
716 INFLUENZA 54 0.0005
717 OEDEMA PERIPHERAL 59 0.0005
718 PERITONITIS 10 0.0005
719 TOOTH EXTRACTION 6 0.0005
720 MOUTH ULCERATION 10 0.0005
721 LABORATORY TEST ABNORMAL 14 0.0005
722 VOMITING 223 0.0005
723 FULL BLOOD COUNT ABNORMAL 5 0.0005
724 ELECTROCARDIOGRAM QT PROLONGED 17 0.0005
725 RENAL DISORDER 22 0.0005
726 NAUSEA 373 0.0005
727 THERAPEUTIC PRODUCT EFFECT DECREASED 21 0.0005
728 CONFUSIONAL STATE 75 0.0005
729 BLOOD MAGNESIUM DECREASED 4 0.0005
730 HAEMATOMA 12 0.0005
731 BLISTER 26 0.0005
732 DEAFNESS 12 0.0005
733 LOCAL SWELLING 8 0.0005
734 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 22 0.0005
735 BURNING SENSATION 32 0.0005
736 GROIN PAIN 4 0.0005
737 UPPER RESPIRATORY TRACT INFECTION 21 0.0005
738 COUGH 127 0.0005
739 DYSPNOEA EXERTIONAL 17 0.0005
740 THIRST 8 0.0004
741 URINARY TRACT INFECTION 76 0.0004
742 MYOCARDIAL ISCHAEMIA 5 0.0004
743 URINARY INCONTINENCE 13 0.0004
744 ALOPECIA 86 0.0004
745 RESPIRATORY DISORDER 13 0.0004
746 TOXICITY TO VARIOUS AGENTS 73 0.0004
747 URTICARIA 72 0.0004
748 MASS 6 0.0004
749 HYPONATRAEMIA 24 0.0004
750 BLOOD URINE PRESENT 8 0.0004
751 DRY EYE 21 0.0004
752 DYSPNOEA 237 0.0004
753 WEIGHT DECREASED 116 0.0004
754 DYSURIA 15 0.0004
755 SKIN EXFOLIATION 34 0.0004
756 BLOOD POTASSIUM DECREASED 12 0.0004
757 FATIGUE 308 0.0004
758 ABDOMINAL PAIN LOWER 10 0.0004
759 HYPOTHERMIA 4 0.0004
760 PRURITUS 151 0.0004
761 BONE PAIN 23 0.0004
762 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 4 0.0004
763 CARDIO-RESPIRATORY ARREST 16 0.0004
764 PULMONARY CONGESTION 5 0.0004
765 INCONTINENCE 4 0.0004
766 LOWER RESPIRATORY TRACT INFECTION 17 0.0004
767 OXYGEN SATURATION DECREASED 21 0.0004
768 BREAST CANCER METASTATIC 4 0.0004
769 NIGHT SWEATS 12 0.0004
770 RENAL INJURY 11 0.0004
771 FRACTURE 7 0.0004
772 INCORRECT PRODUCT ADMINISTRATION DURATION 8 0.0004
773 GASTRIC ULCER 7 0.0004
774 PROTEINURIA 7 0.0004
775 ASPIRATION 4 0.0004
776 ABASIA 9 0.0004
777 GENERALISED TONIC-CLONIC SEIZURE 6 0.0004
778 THROMBOSIS 29 0.0004
779 HYPERTENSIVE CRISIS 4 0.0004
780 HAEMORRHOIDS 7 0.0004
781 WRONG TECHNIQUE IN DRUG USAGE PROCESS 13 0.0004
782 GASTROINTESTINAL DISORDER 32 0.0004
783 KIDNEY INFECTION 7 0.0004
784 SPINAL FRACTURE 7 0.0003
785 PARALYSIS 5 0.0003
786 HAEMORRHAGE 36 0.0003
787 METABOLIC ACIDOSIS 11 0.0003
788 APATHY 5 0.0003
789 DRUG INEFFECTIVE 451 0.0003
790 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 10 0.0003
791 BACK PAIN 79 0.0003
792 SKIN HAEMORRHAGE 5 0.0003
793 FLATULENCE 19 0.0003
794 HEART RATE INCREASED 33 0.0003
795 APHASIA 10 0.0003
796 CONTRAINDICATED PRODUCT ADMINISTERED 10 0.0003
797 LETHARGY 19 0.0003
798 SUICIDE ATTEMPT 20 0.0003
799 ILL-DEFINED DISORDER 20 0.0003
800 PRESYNCOPE 8 0.0003
801 EATING DISORDER 7 0.0003
802 DEPRESSED LEVEL OF CONSCIOUSNESS 13 0.0003
803 DYSPHAGIA 31 0.0003
804 ARTHROPATHY 18 0.0003
805 ABNORMAL WEIGHT GAIN 4 0.0003
806 HAEMOPTYSIS 9 0.0003
807 DEMENTIA 9 0.0003
808 CYANOSIS 5 0.0003
809 ANGINA PECTORIS 9 0.0003
810 CARDIAC FAILURE CONGESTIVE 25 0.0003
811 GASTROINTESTINAL HAEMORRHAGE 26 0.0003
812 ANOREXIA 4 0.0003
813 BLOOD POTASSIUM INCREASED 5 0.0003
814 TREMOR 51 0.0003
815 SKIN FISSURES 6 0.0003
816 ECZEMA 16 0.0003
817 MYOCARDIAL INFARCTION 53 0.0003
818 CHEST DISCOMFORT 31 0.0003
819 HYPERTENSION 64 0.0003
820 UPPER LIMB FRACTURE 6 0.0003
821 MALAISE 132 0.0003
822 PERICARDITIS 5 0.0003
823 CHEST PAIN 55 0.0003
824 GINGIVAL BLEEDING 4 0.0003
825 ARTHRITIS 23 0.0003
826 RESPIRATORY ARREST 8 0.0003
827 DIABETES MELLITUS 22 0.0003
828 CONDITION AGGRAVATED 86 0.0003
829 BRADYCARDIA 15 0.0003
830 RETCHING 6 0.0003
831 MOVEMENT DISORDER 9 0.0003
832 HYPERHIDROSIS 36 0.0003
833 SWELLING FACE 18 0.0003
834 GASTRIC CANCER 7 0.0003
835 MUSCULOSKELETAL STIFFNESS 24 0.0003
836 SINUSITIS 28 0.0003
837 PRODUCTIVE COUGH 13 0.0003
838 VISUAL ACUITY REDUCED 9 0.0003
839 DIPLOPIA 7 0.0003
840 DYSGEUSIA 20 0.0003
841 LUNG NEOPLASM MALIGNANT 11 0.0003
842 BLOOD SODIUM DECREASED 5 0.0003
843 MUSCULAR WEAKNESS 30 0.0003
844 BLOOD PRESSURE INCREASED 40 0.0003
845 PARAESTHESIA 41 0.0003
846 PALLOR 7 0.0003
847 SWOLLEN TONGUE 8 0.0003
848 PERIPHERAL SWELLING 39 0.0003
849 HEPATIC CANCER 6 0.0002
850 MYALGIA 42 0.0002
851 LACTIC ACIDOSIS 8 0.0002
852 BLOOD CREATINE PHOSPHOKINASE INCREASED 7 0.0002
853 FLUID RETENTION 12 0.0002
854 COGNITIVE DISORDER 11 0.0002
855 LIVER FUNCTION TEST INCREASED 5 0.0002
856 SKIN CANCER 5 0.0002
857 PRURITUS GENERALISED 5 0.0002
858 PRODUCT PRESCRIBING ISSUE 5 0.0002
859 COLD SWEAT 4 0.0002
860 OROPHARYNGEAL PAIN 21 0.0002
861 ANGIOEDEMA 10 0.0002
862 HEAD DISCOMFORT 4 0.0002
863 EAR INFECTION 6 0.0002
864 FALL 75 0.0002
865 UNEVALUABLE EVENT 17 0.0002
866 JOINT SWELLING 27 0.0002
867 PAIN OF SKIN 6 0.0002
868 THROAT TIGHTNESS 6 0.0002
869 HEAD INJURY 7 0.0002
870 LOSS OF CONSCIOUSNESS 28 0.0002
871 SKIN DISCOLOURATION 10 0.0002
872 NASOPHARYNGITIS 40 0.0002
873 EYE SWELLING 8 0.0002
874 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 5 0.0002
875 DRUG INTERACTION 34 0.0002
876 FEELING HOT 13 0.0002
877 HYPOAESTHESIA 31 0.0002
878 NEURALGIA 5 0.0002
879 WHEEZING 12 0.0002
880 OSTEONECROSIS OF JAW 5 0.0002
881 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
882 COLITIS ULCERATIVE 9 0.0002
883 EPILEPSY 6 0.0002
884 LIMB DISCOMFORT 6 0.0002
885 UNRESPONSIVE TO STIMULI 5 0.0002
886 PAIN IN EXTREMITY 57 0.0002
887 SWELLING 18 0.0002
888 RHABDOMYOLYSIS 8 0.0002
889 ABDOMINAL DISTENSION 20 0.0002
890 ABDOMINAL DISCOMFORT 32 0.0002
891 GASTRITIS 5 0.0002
892 PALPITATIONS 22 0.0002
893 INSOMNIA 50 0.0002
894 RHEUMATOID ARTHRITIS 21 0.0002
895 IMPAIRED HEALING 6 0.0002
896 HAEMATOCHEZIA 10 0.0002
897 ABNORMAL DREAMS 5 0.0002
898 DIZZINESS 90 0.0002
899 DISCOMFORT 11 0.0002
900 LIP SWELLING 6 0.0002
901 TRANSIENT ISCHAEMIC ATTACK 6 0.0002
902 INCORRECT DRUG ADMINISTRATION DURATION 5 0.0002
903 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 6 0.0002
904 CONTUSION 17 0.0002
905 PAIN 107 0.0002
906 HEADACHE 109 0.0002
907 EPISTAXIS 13 0.0002
908 DRY MOUTH 14 0.0002
909 SPEECH DISORDER 9 0.0002
910 CHRONIC KIDNEY DISEASE 13 0.0002
911 HEART RATE DECREASED 6 0.0002
912 WEIGHT INCREASED 38 0.0002
913 UNDERDOSE 12 0.0002
914 DYSPEPSIA 16 0.0002
915 DEPRESSION 37 0.0002
916 FEMUR FRACTURE 5 0.0002
917 ARTHRALGIA 67 0.0002
918 DRUG-INDUCED LIVER INJURY 5 0.0002
919 HOT FLUSH 12 0.0002
920 CARDIOVASCULAR DISORDER 4 0.0002
921 HYPOTHYROIDISM 5 0.0002
922 THERAPY CESSATION 8 0.0002
923 BLADDER CANCER 9 0.0002
924 DISTURBANCE IN ATTENTION 8 0.0001
925 POLLAKIURIA 6 0.0001
926 ABDOMINAL PAIN UPPER 29 0.0001
927 RHINORRHOEA 9 0.0001
928 DYSSTASIA 4 0.0001
929 PROSTATE CANCER 11 0.0001
930 MUSCLE SPASMS 25 0.0001
931 INJECTION SITE MASS 5 0.0001
932 THROAT IRRITATION 6 0.0001
933 MUSCULOSKELETAL PAIN 7 0.0001
934 CORONARY ARTERY DISEASE 4 0.0001
935 VERTIGO 8 0.0001
936 NEPHROLITHIASIS 6 0.0001
937 INJECTION SITE REACTION 9 0.0001
938 TINNITUS 6 0.0001
939 COMA 6 0.0001
940 NECK PAIN 7 0.0001
941 HYPOGLYCAEMIA 6 0.0001
942 AMNESIA 8 0.0001
943 AGITATION 9 0.0001
944 EYE DISORDER 4 0.0001
945 SEIZURE 14 0.0001
946 INJECTION SITE PAIN 37 0.0001
947 GAIT DISTURBANCE 23 0.0001
948 DRY SKIN 16 0.0001
949 NEOPLASM MALIGNANT 8 0.0001
950 DYSPHONIA 7 0.0001
951 ADVERSE EVENT 11 0.0001
952 NASAL CONGESTION 7 0.0001
953 OSTEOARTHRITIS 5 0.0001
954 CATARACT 7 0.0001
955 CEREBROVASCULAR ACCIDENT 19 0.0001
956 GASTROOESOPHAGEAL REFLUX DISEASE 9 0.0001
957 BLOOD GLUCOSE INCREASED 21 0.0001
958 MOBILITY DECREASED 8 0.0001
959 CONVULSION 6 0.0001
960 VISUAL IMPAIRMENT 13 0.0001
961 ABNORMAL BEHAVIOUR 4 0.0001
962 THERAPY INTERRUPTED 7 0.0001
963 HALLUCINATION 7 0.0001
964 ACNE 7 0.0001
965 NO ADVERSE EVENT 16 0.0001
966 FEELING ABNORMAL 21 0.0001
967 ACCIDENTAL EXPOSURE TO PRODUCT 9 0.0001
968 EYE IRRITATION 5 0.0001
969 BLOOD GLUCOSE DECREASED 4 0.0001
970 BALANCE DISORDER 7 0.0001
971 MEMORY IMPAIRMENT 11 0.0001
972 INTENTIONAL OVERDOSE 5 0.0001
973 SOMNOLENCE 15 0.0001
974 ANXIETY 21 0.0001
975 ADVERSE DRUG REACTION 6 0.0001
976 HOSPITALISATION 10 0.0001
977 OVERDOSE 11 0.0001
978 ILLNESS 5 0.0000
979 INJECTION SITE ERYTHEMA 6 0.0000
980 INCORRECT DOSE ADMINISTERED 11 0.0000
981 ASTHMA 5 0.0000
982 VISION BLURRED 6 0.0000
983 BREAST CANCER 4 0.0000
984 DRUG DOSE OMISSION 6 0.0000
985 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 7 0.0000
986 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
987 PRODUCT DOSE OMISSION ISSUE 5 0.0000